Wei-Chun Lin

801 total citations
41 papers, 520 citations indexed

About

Wei-Chun Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Wei-Chun Lin has authored 41 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Wei-Chun Lin's work include Electronic Health Records Systems (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Glaucoma and retinal disorders (4 papers). Wei-Chun Lin is often cited by papers focused on Electronic Health Records Systems (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Glaucoma and retinal disorders (4 papers). Wei-Chun Lin collaborates with scholars based in United States, China and Taiwan. Wei-Chun Lin's co-authors include Chao Hsing Yeh, Lung-Chang Chien, Dana H. Bovbjerg, Liye Zou, Yang Liu, Jiajia Ye, Kathryn M. Albers, Natalia E. Morone, Chun-Ming Tsai and Reury-Perng Perng and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Journal of Cancer.

In The Last Decade

Wei-Chun Lin

37 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei-Chun Lin United States 12 109 105 98 90 62 41 520
Fang Zuo China 11 54 0.5× 56 0.5× 128 1.3× 23 0.3× 86 1.4× 30 428
Patrick Chang United States 13 128 1.2× 134 1.3× 56 0.6× 31 0.3× 99 1.6× 40 563
Xiaoli Zhang China 12 28 0.3× 52 0.5× 87 0.9× 57 0.6× 159 2.6× 37 604
Shan Huang China 14 73 0.7× 84 0.8× 34 0.3× 14 0.2× 159 2.6× 48 602
Mehtap Bozkurt Türkiye 15 21 0.2× 58 0.6× 41 0.4× 40 0.4× 106 1.7× 50 643
Abdullah Taşlıpınar Türkiye 15 68 0.6× 30 0.3× 42 0.4× 83 0.9× 224 3.6× 47 800
Gianluca Giubilei Italy 17 46 0.4× 69 0.7× 431 4.4× 47 0.5× 189 3.0× 34 1.4k
Sang-Hoon Yoon South Korea 12 129 1.2× 31 0.3× 16 0.2× 116 1.3× 153 2.5× 53 633
Tso‐Chou Lin Taiwan 14 14 0.1× 32 0.3× 48 0.5× 51 0.6× 62 1.0× 55 598
Sara Fleming United States 6 97 0.9× 36 0.3× 8 0.1× 42 0.5× 55 0.9× 9 1.1k

Countries citing papers authored by Wei-Chun Lin

Since Specialization
Citations

This map shows the geographic impact of Wei-Chun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Chun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Chun Lin more than expected).

Fields of papers citing papers by Wei-Chun Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-Chun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Chun Lin. The network helps show where Wei-Chun Lin may publish in the future.

Co-authorship network of co-authors of Wei-Chun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-Chun Lin. A scholar is included among the top collaborators of Wei-Chun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-Chun Lin. Wei-Chun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gowrisankaran, Sowjanya, Wei-Chun Lin, Xubo Song, et al.. (2025). A Hybrid Deep Learning–Based Approach for Visual Field Test Forecasting. Ophthalmology Science. 5(5). 100803–100803.
2.
Lin, Wei-Chun, et al.. (2025). Mitomycin C in Ahmed Glaucoma Valve Implant Affects Surgical Outcomes. Bioengineering. 12(8). 859–859.
3.
Liang, Pan, Wei-Chun Lin, Quentin G. Wright, et al.. (2025). External Testing of a Commercial AI Algorithm for Breast Cancer Detection at Screening Mammography. Radiology Artificial Intelligence. 7(3). e240287–e240287. 2 indexed citations
4.
Lin, Wei-Chun, et al.. (2024). Expression of histone methyltransferase WHSC1 in invasive breast cancer and its correlation with clinical and pathological data. Pathology - Research and Practice. 263. 155647–155647.
5.
Lin, Wei-Chun, et al.. (2024). High Prevalence of Artifacts in Optical Coherence Tomography With Adequate Signal Strength. Translational Vision Science & Technology. 13(8). 43–43. 1 indexed citations
6.
Chen, Shuling, Wei-Chun Lin, Chao‐Wei Lee, et al.. (2022). The Characteristics and Mortality of Chinese Herbal Medicine Users among Newly Diagnosed Inoperable Huge Hepatocellular Carcinoma (≥10 cm) Patients: A Retrospective Cohort Study with Exploration of Core Herbs. International Journal of Environmental Research and Public Health. 19(19). 12480–12480. 6 indexed citations
7.
Chen, Shuling, Wei-Chun Lin, Yu‐Chun Chen, et al.. (2022). The association between mortality and use of Chinese herbal medicine among incident stage IV esophageal cancer patients: A retrospective cohort study with core herbs exploration. Frontiers in Pharmacology. 13. 1018281–1018281. 3 indexed citations
8.
Lin, Wei-Chun, et al.. (2021). Medication List Extraction Using Natural Language Processing for Glaucoma Patients. Investigative Ophthalmology & Visual Science. 62(8). 1001–1001. 1 indexed citations
9.
Chen, Jimmy, et al.. (2021). Discrepancies in Ophthalmic Medication Documentation for Glaucoma Patients. SHILAP Revista de lepidopterología. 2(1). 100091–100091.
10.
Lin, Wei-Chun, Jingjing Wang, Xiuming Xu, et al.. (2020). Rapid propagation in vitro and accumulation of active substances of endangered Dendrobium cariniferum Rchb. f. Bioengineered. 11(1). 386–396. 9 indexed citations
11.
12.
Zheng, Beihong, et al.. (2020). A meta-analysis of the efficacy of progestin-primed ovarian stimulation with medroxyprogesterone acetate in ovulation induction in poor ovarian responders. Journal of Gynecology Obstetrics and Human Reproduction. 50(7). 102049–102049. 10 indexed citations
13.
Rizvi, Naiyer A., David R. Gandara, Benjamin Solomon, et al.. (2018). P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC with Atezolizumab + Chemotherapy. Journal of Thoracic Oncology. 13(10). S863–S863. 7 indexed citations
14.
Yeh, Chao Hsing, Wei-Chun Lin, Lorna Kwai Ping Suen, et al.. (2017). Auricular Point Acupressure to Manage Aromatase Inhibitor–Induced Arthralgia in Postmenopausal Breast Cancer Survivors: A Pilot Study. Oncology nursing forum. 44(4). 476–487. 22 indexed citations
15.
16.
Chiu, Hsien‐Yi, Chien-Hsun Li, Wei-Chun Lin, et al.. (2015). Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications – A National Population-Based Cohort Study. PLoS ONE. 10(9). e0136508–e0136508. 72 indexed citations
17.
Lin, Wei-Chun, Hong-Mo Shih, & Leng-Chieh Lin. (2015). Preliminary Prospective Study to Assess the Effect of Early Blood Urea Nitrogen/Creatinine Ratio-Based Hydration Therapy on Poststroke Infection Rate and Length of Stay in Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 24(12). 2720–2727. 17 indexed citations
18.
19.
Chen, Yuh-Min, et al.. (2003). Phase II Study of Gemcitabine and Vinorelbine Combination Chemotherapy in Patients With Non–Small-Cell Lung Cancer Not Responding to Previous Chemotherapy. American Journal of Clinical Oncology. 26(6). 567–570. 15 indexed citations
20.
Liu, Jacqueline Ming, Ming‐Fang Wu, Wei-Chun Lin, et al.. (1998). Ifosfamide-based chemotherapy for previously treated lung cancer patients.. PubMed. 61(7). 389–96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fang Zuo Breakdown of academic impact, for papers by Patrick Chang Breakdown of academic impact, for papers by Xiaoli Zhang Breakdown of academic impact, for papers by Shan Huang Breakdown of academic impact, for papers by Mehtap Bozkurt Breakdown of academic impact, for papers by Abdullah Taşlıpınar Breakdown of academic impact, for papers by Gianluca Giubilei Breakdown of academic impact, for papers by Sang-Hoon Yoon Breakdown of academic impact, for papers by Tso‐Chou Lin Breakdown of academic impact, for papers by Sara Fleming
Rankless by CCL
2026